ID   GNA1_HUMAN              Reviewed;         184 AA.
AC   Q96EK6;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 139.
DE   RecName: Full=Glucosamine 6-phosphate N-acetyltransferase;
DE            EC=2.3.1.4 {ECO:0000269|PubMed:18601654, ECO:0000269|PubMed:18675810};
DE   AltName: Full=Phosphoglucosamine acetylase;
DE   AltName: Full=Phosphoglucosamine transacetylase;
GN   Name=GNPNAT1; Synonyms=GNA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH THE SUBSTRATE
RP   GLUCOSAMINE-6-PHOSPHATE, CATALYTIC ACTIVITY, MUTAGENESIS OF GLU-156,
RP   AND SUBUNIT.
RX   PubMed=18675810; DOI=10.1016/j.febslet.2008.07.040;
RA   Wang J., Liu X., Liang Y.-H., Li L.-F., Su X.-D.;
RT   "Acceptor substrate binding revealed by crystal structure of human
RT   glucosamine-6-phosphate N-acetyltransferase 1.";
RL   FEBS Lett. 582:2973-2978(2008).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH THE ACETYL-COA
RP   ANALOG COENZYME A AND THE SUBSTRATE N-ACETYLGLUCOSAMINE-6-PHOSPHATE,
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18601654; DOI=10.1042/BJ20081000;
RA   Hurtado-Guerrero R., Raimi O.G., Min J., Zeng H., Vallius L.,
RA   Shepherd S., Ibrahim A.F.M., Wu H., Plotnikov A.N., van Aalten D.M.F.;
RT   "Structural and kinetic differences between human and Aspergillus
RT   fumigatus D-glucosamine-6-phosphate N-acetyltransferase.";
RL   Biochem. J. 415:217-223(2008).
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + D-glucosamine 6-phosphate = CoA +
CC       N-acetyl-D-glucosamine 6-phosphate. {ECO:0000269|PubMed:18601654,
CC       ECO:0000269|PubMed:18675810}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=26 uM for acetyl-coenzyme A {ECO:0000269|PubMed:18601654};
CC         KM=97 uM for glucosamine-6-phosphate
CC         {ECO:0000269|PubMed:18601654};
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; N-acetyl-alpha-D-glucosamine 1-phosphate
CC       from alpha-D-glucosamine 6-phosphate (route I): step 1/2.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:18601654,
CC       ECO:0000269|PubMed:18675810}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-3913338, EBI-3913338;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Peripheral
CC       membrane protein. Endosome membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the acetyltransferase family. GNA1
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK090577; BAC03482.1; -; mRNA.
DR   EMBL; BC012179; AAH12179.1; -; mRNA.
DR   CCDS; CCDS9712.1; -.
DR   RefSeq; NP_932332.1; NM_198066.3.
DR   RefSeq; XP_005268069.1; XM_005268012.2.
DR   RefSeq; XP_006720301.1; XM_006720238.3.
DR   UniGene; Hs.478025; -.
DR   PDB; 2HUZ; X-ray; 2.67 A; A/B=1-184.
DR   PDB; 2O28; X-ray; 1.80 A; A/B=1-184.
DR   PDB; 3CXP; X-ray; 2.01 A; A=1-184.
DR   PDB; 3CXQ; X-ray; 2.30 A; A=1-184.
DR   PDB; 3CXS; X-ray; 2.70 A; A=1-184.
DR   PDBsum; 2HUZ; -.
DR   PDBsum; 2O28; -.
DR   PDBsum; 3CXP; -.
DR   PDBsum; 3CXQ; -.
DR   PDBsum; 3CXS; -.
DR   ProteinModelPortal; Q96EK6; -.
DR   SMR; Q96EK6; -.
DR   BioGrid; 122317; 18.
DR   IntAct; Q96EK6; 4.
DR   MINT; MINT-2813920; -.
DR   STRING; 9606.ENSP00000216410; -.
DR   iPTMnet; Q96EK6; -.
DR   PhosphoSitePlus; Q96EK6; -.
DR   BioMuta; GNPNAT1; -.
DR   DMDM; 47116568; -.
DR   EPD; Q96EK6; -.
DR   MaxQB; Q96EK6; -.
DR   PaxDb; Q96EK6; -.
DR   PeptideAtlas; Q96EK6; -.
DR   PRIDE; Q96EK6; -.
DR   Ensembl; ENST00000216410; ENSP00000216410; ENSG00000100522.
DR   GeneID; 64841; -.
DR   KEGG; hsa:64841; -.
DR   UCSC; uc001xab.4; human.
DR   CTD; 64841; -.
DR   GeneCards; GNPNAT1; -.
DR   HGNC; HGNC:19980; GNPNAT1.
DR   HPA; HPA044647; -.
DR   MIM; 616510; gene.
DR   neXtProt; NX_Q96EK6; -.
DR   OpenTargets; ENSG00000100522; -.
DR   PharmGKB; PA134901326; -.
DR   eggNOG; KOG3396; Eukaryota.
DR   eggNOG; COG0454; LUCA.
DR   GeneTree; ENSGT00390000008666; -.
DR   HOGENOM; HOG000106325; -.
DR   HOVERGEN; HBG048986; -.
DR   InParanoid; Q96EK6; -.
DR   KO; K00621; -.
DR   OMA; GRGCYKV; -.
DR   OrthoDB; EOG091G0EMF; -.
DR   PhylomeDB; Q96EK6; -.
DR   TreeFam; TF313790; -.
DR   BRENDA; 2.3.1.4; 2681.
DR   Reactome; R-HSA-446210; Synthesis of UDP-N-acetyl-glucosamine.
DR   SABIO-RK; Q96EK6; -.
DR   UniPathway; UPA00113; UER00529.
DR   ChiTaRS; GNPNAT1; human.
DR   EvolutionaryTrace; Q96EK6; -.
DR   GenomeRNAi; 64841; -.
DR   PRO; PR:Q96EK6; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100522; -.
DR   CleanEx; HS_GNPNAT1; -.
DR   ExpressionAtlas; Q96EK6; baseline and differential.
DR   Genevisible; Q96EK6; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IEA:Ensembl.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0004343; F:glucosamine 6-phosphate N-acetyltransferase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0048029; F:monosaccharide binding; IEA:Ensembl.
DR   GO; GO:0006041; P:glucosamine metabolic process; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; IEA:Ensembl.
DR   GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; IBA:GO_Central.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR000182; GNAT_dom.
DR   Pfam; PF00583; Acetyltransf_1; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51186; GNAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Complete proteome; Endosome;
KW   Golgi apparatus; Membrane; Reference proteome; Transferase.
FT   CHAIN         1    184       Glucosamine 6-phosphate N-
FT                                acetyltransferase.
FT                                /FTId=PRO_0000074553.
FT   DOMAIN       39    184       N-acetyltransferase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00532}.
FT   REGION      108    111       Substrate binding. {ECO:0000244|PDB:3CXQ,
FT                                ECO:0000269|PubMed:18675810,
FT                                ECO:0000305|PubMed:18601654}.
FT   REGION      120    122       Substrate binding. {ECO:0000244|PDB:3CXQ,
FT                                ECO:0000269|PubMed:18675810,
FT                                ECO:0000305|PubMed:18601654}.
FT   REGION      130    135       Acetyl-CoA binding.
FT                                {ECO:0000244|PDB:2O28,
FT                                ECO:0000305|PubMed:18601654}.
FT   REGION      151    152       Substrate binding. {ECO:0000244|PDB:3CXQ,
FT                                ECO:0000269|PubMed:18675810,
FT                                ECO:0000305|PubMed:18601654}.
FT   REGION      165    167       Acetyl-CoA binding.
FT                                {ECO:0000244|PDB:2O28,
FT                                ECO:0000305|PubMed:18601654}.
FT   BINDING      61     61       Substrate. {ECO:0000244|PDB:3CXQ,
FT                                ECO:0000269|PubMed:18675810,
FT                                ECO:0000305|PubMed:18601654}.
FT   BINDING     175    175       Substrate. {ECO:0000244|PDB:3CXQ,
FT                                ECO:0000269|PubMed:18675810,
FT                                ECO:0000305|PubMed:18601654}.
FT   BINDING     181    181       Substrate. {ECO:0000244|PDB:3CXQ,
FT                                ECO:0000269|PubMed:18675810,
FT                                ECO:0000305|PubMed:18601654}.
FT   MUTAGEN     156    156       E->A: Reduces affinity for glucosamine-6-
FT                                phosphate 6-fold.
FT                                {ECO:0000269|PubMed:18675810}.
FT   MUTAGEN     156    156       E->D: Slightly reduced catalytic
FT                                activity. {ECO:0000269|PubMed:18675810}.
FT   STRAND        7      9       {ECO:0000244|PDB:2O28}.
FT   HELIX        12     16       {ECO:0000244|PDB:2O28}.
FT   HELIX        19     21       {ECO:0000244|PDB:2O28}.
FT   STRAND       32     34       {ECO:0000244|PDB:3CXQ}.
FT   STRAND       39     43       {ECO:0000244|PDB:2O28}.
FT   HELIX        46     50       {ECO:0000244|PDB:2O28}.
FT   HELIX        53     57       {ECO:0000244|PDB:2O28}.
FT   TURN         58     60       {ECO:0000244|PDB:2O28}.
FT   HELIX        68     81       {ECO:0000244|PDB:2O28}.
FT   STRAND       84     91       {ECO:0000244|PDB:2O28}.
FT   TURN         92     95       {ECO:0000244|PDB:2O28}.
FT   STRAND       96    107       {ECO:0000244|PDB:2O28}.
FT   HELIX       110    113       {ECO:0000244|PDB:2O28}.
FT   STRAND      115    124       {ECO:0000244|PDB:2O28}.
FT   HELIX       126    128       {ECO:0000244|PDB:2O28}.
FT   HELIX       133    147       {ECO:0000244|PDB:2O28}.
FT   STRAND      150    157       {ECO:0000244|PDB:2O28}.
FT   HELIX       159    161       {ECO:0000244|PDB:2O28}.
FT   HELIX       162    166       {ECO:0000244|PDB:2O28}.
FT   TURN        167    169       {ECO:0000244|PDB:2O28}.
FT   STRAND      174    182       {ECO:0000244|PDB:2O28}.
SQ   SEQUENCE   184 AA;  20749 MW;  E9F31803CF633BBF CRC64;
     MKPDETPMFD PSLLKEVDWS QNTATFSPAI SPTHPGEGLV LRPLCTADLN RGFFKVLGQL
     TETGVVSPEQ FMKSFEHMKK SGDYYVTVVE DVTLGQIVAT ATLIIEHKFI HSCAKRGRVE
     DVVVSDECRG KQLGKLLLST LTLLSKKLNC YKITLECLPQ NVGFYKKFGY TVSEENYMCR
     RFLK
//
